2023 AAFP CME Symposium - Optimizing Outcomes in Patients with Hyperkalemia: Exploring the Role of the Family Physician

HAZLET, N.J. - EntSun -- In this program, experts will discuss the risk factors for, and risks of hyperkalemia, treatment goals of  acute and chronic hyperkalemia, the importance of RAASi in CKD and HF patients, the potential adverse outcomes in individuals with ESRD undergoing adequate hemodialysis with predialysis hyperkalemia,  and evidence with K+ binders in various patient populations. A multi-specialty faculty, consisting of two nephrologists, a dietician, and a primary care physician, will then discuss cardiorenal challenges faced by family physicians, including dietary recommendations to their patients with hyperkalemia. In addition, the panel will identify key cardiorenal messages for patients taking K+ binders (for hyperkalemia) and sodium-glucose cotransporter 2 (SGLT2) inhibitors which reduce the risk for hyperkalemia and significantly improve cardiorenal outcomes.

More on EntSun News

• Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
• GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
• Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety
• Yvette Kendall Secures $6 Million Deal with The Sessions Studios for Horror Thriller, "NORTH"
• Sisu, a Portrait of Grit, Connection and Triumph, Premieres on Documentary Showcase

Click here for more information

CHAIR

Csaba P. Kovesdy, MD
Fred Hatch Professor of Medicine
Director, Clinical Outcomes and Clinical Trials Program in Nephrology
University of Tennessee Health Science Center
Memphis VA Medical Center
Memphis, Tennessee

FACULTY

Deborah Clegg, PhD
Vice President for Research
Texas Tech University Health Sciences Center El Paso
Professor of Internal Medicine
Paul L. Foster School of Medicine El Paso, Texas

Jay Shubrook, DO
Professor, Primary Care Department
Touro University California College of Osteopathic Medicine
Vallejo, California

Bruce Spinowitz, MD
Associate Director, Nephrology
Vice Chairman, Medicine
New York-Presbyterian Queens
Professor of Clinical Medicine
Weill Cornell Medical College
New York, New York

This educational activity is intended for primary care physicians and other clinicians managing patients at risk for, and with hyperkalemia.

More on EntSun News

• The Blue Luna Encourages Local Schools to Take Steps to Enhance Safety for Students and Staff
• The Sessions Studios Secures $300 Million Commitment to Launch World-Class Studio and 15-Film Global Slate
• Smart Resnse Unveils Smart Resnse(SRMS) Token-Powered AI Orchestration Platform to Revolutionize Multi-Billion Dollar Market
• Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request
• The Battle for the Enchanted Forest Brings Fantasy, Fun, and Fundraising!

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certifi cate of completion as AANP accepts AMA PRA Category 1.5 Credits™ through its reciprocity agreements.

Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #AAFPFMX #hyperkalemia #physician #potassium #cardiorenal #diet